Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis

NCT03250624 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT03250624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03250624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis
Lead sponsor
Galderma R&D
Phase
Phase 2
Overall status
Completed
Start date
November 1, 2016
Completion date
June 26, 2017
Enrollment
63 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis